Unrecognized Tax Benefits of ENANTA PHARMACEUTICALS INC from 30 Sep 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
ENANTA PHARMACEUTICALS INC quarterly Unrecognized Tax Benefits in USD history and change rate from 30 Sep 2012 to 30 Sep 2025.
  • ENANTA PHARMACEUTICALS INC Unrecognized Tax Benefits for the quarter ending 30 Sep 2025 was $892,000, a 1.4% decline year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

ENANTA PHARMACEUTICALS INC Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $892,000 -$13,000 -1.4% 30 Sep 2025 10-K 19 Nov 2025 2025 FY
Q3 2024 $905,000 -$151,000 -14% 30 Sep 2024 10-K 19 Nov 2025 2025 FY
Q3 2023 $1,056,000 +$830,000 +367% 30 Sep 2023 10-K 19 Nov 2025 2025 FY
Q3 2022 $226,000 -$396,000 -64% 30 Sep 2022 10-K 27 Nov 2024 2024 FY
Q3 2021 $622,000 -$222,000 -26% 30 Sep 2021 10-K 22 Nov 2023 2023 FY
Q2 2021 $529,000 -$247,000 -32% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q3
Q1 2021 $686,000 -$78,000 -10% 31 Mar 2021 10-Q 10 May 2021 2021 Q2
Q4 2020 $675,000 -$1,004,000 -60% 31 Dec 2020 10-Q 09 Feb 2021 2021 Q1
Q3 2020 $844,000 -$806,000 -49% 30 Sep 2020 10-K 23 Nov 2022 2022 FY
Q2 2020 $776,000 -$1,089,000 -58% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q3
Q1 2020 $764,000 -$1,158,000 -60% 31 Mar 2020 10-Q 11 May 2020 2020 Q2
Q4 2019 $1,679,000 $0 0% 31 Dec 2019 10-Q 10 Feb 2020 2020 Q1
Q3 2019 $1,650,000 -$29,000 -1.7% 30 Sep 2019 10-K 24 Nov 2021 2021 FY
Q2 2019 $1,865,000 +$372,000 +25% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q3
Q1 2019 $1,922,000 +$483,000 +34% 31 Mar 2019 10-Q 10 May 2019 2019 Q2
Q4 2018 $1,679,000 +$491,000 +41% 31 Dec 2018 10-K 25 Nov 2020 2020 FY
Q3 2018 $1,679,000 +$504,000 +43% 30 Sep 2018 10-K 27 Nov 2019 2019 FY
Q2 2018 $1,493,000 +$384,000 +35% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q3
Q1 2018 $1,439,000 +$373,000 +35% 31 Mar 2018 10-Q 10 May 2018 2018 Q2
Q4 2017 $1,188,000 +$123,000 +12% 31 Dec 2017 10-Q 09 Feb 2018 2018 Q1
Q3 2017 $1,175,000 +$430,000 +58% 30 Sep 2017 10-K 27 Nov 2019 2019 FY
Q2 2017 $1,109,000 +$441,000 +66% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q3
Q1 2017 $1,066,000 +$556,000 +109% 31 Mar 2017 10-Q 10 May 2017 2017 Q2
Q4 2016 $1,065,000 +$567,000 +114% 31 Dec 2016 10-Q 09 Feb 2017 2017 Q1
Q3 2016 $745,000 +$297,000 +66% 30 Sep 2016 10-K 29 Nov 2018 2018 FY
Q2 2016 $668,000 +$568,000 +568% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q3
Q1 2016 $510,000 +$510,000 31 Mar 2016 10-Q 10 May 2016 2016 Q2
Q4 2015 $498,000 +$498,000 31 Dec 2015 10-Q 09 Feb 2016 2016 Q1
Q3 2015 $448,000 +$448,000 30 Sep 2015 10-K 11 Dec 2017 2017 FY
Q2 2015 $100,000 30 Jun 2015 10-Q 10 Aug 2015 2015 Q3
Q1 2015 $0 31 Mar 2015 10-Q 08 May 2015 2015 Q2
Q4 2014 $0 31 Dec 2014 10-Q 06 Feb 2015 2015 Q1
Q3 2014 $0 $0 30 Sep 2014 10-K 11 Dec 2015 2015 FY
Q3 2013 $0 $0 30 Sep 2013 10-K 11 Dec 2014 2014 FY
Q3 2012 $0 30 Sep 2012 10-K 11 Dec 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.